Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma

Arch Gynecol Obstet. 1988;243(4):235-6. doi: 10.1007/BF00932274.

Abstract

Hematometra developed in a patient receiving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / radiotherapy*
  • Drug Therapy, Combination
  • Estrogens, Conjugated (USP) / adverse effects*
  • Female
  • Hematometra / chemically induced*
  • Humans
  • Medroxyprogesterone / adverse effects*
  • Middle Aged
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / radiotherapy*

Substances

  • Estrogens, Conjugated (USP)
  • Medroxyprogesterone